RNWL
INTERNATIONAL REGISTRATION RENEWED
11/25/2024
Back to search
Official data from USPTO
TAKATA PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
11/25/2024
Trademark type
Combined
Nice classes
5
Filing date
02/14/2022
Registration date
07/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/04/2023
Last transaction
07/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
JP
Examiner
MCCAULEY, BRENDAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "TAKATA PHARMACEUTICAL". The letters "T" and the letter "K" in the word "TAKATA" are dark blue and the letters "A" in the word "TAKATA" are light blue. The word "PHARMACUETICAL" is in dark blue. To the left of the wording is an image of a flower with one side in pink and one side which transitions from light blue to dark blue. An incomplete circle appears through the flower in dark blue and in light blue as it intersects the flower. The flower has a white center and white lines which represent transparent areas and are not part of the mark.
Holders and representatives
Holders
TAKATA Pharmaceutical Co., Ltd.
Representatives
Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsanti-cancer drugs in the nature of anti-cancer preparations and pharmaceutical products for the treatment of cancer; pharmaceutical preparationsantibiotics; preparations for destroying vermin; fungicides; herbicides; nutritional additives for medical purposes for use in food and dietary supplements for human consumptionnutritional food additives for medical purposes in the nature of natural food extracts derived from fishmeatvegetables; nutritional additives for medical purposes for use in foodanimal feed additive for use as a nutritional supplement for medical purposes; medicinal tonics and substitutes therefor in the nature of nutritional food and drink additives containing vitamins and nutrients for health and medical purposesnon-medicated additives for animal feed for use as nutritional supplementsmedicated oils containing vitamins and mineralsnutritional food additives for medical purposes in the nature of food extracts derived from fishmeatvegetables; dietary supplements for humans
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/31/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/06/2023
FIMP
FINAL DISPOSITION PROCESSED
10/06/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2023
GPNX
NOTIFICATION PROCESSED BY IB
05/09/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2023
PUBO
PUBLISHED FOR OPPOSITION
04/18/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/14/2023
RFNT
REFUSAL PROCESSED BY IB
02/27/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/30/2023
RFRR
REFUSAL PROCESSED BY MPU
01/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/01/2022
CNRT
NON-FINAL ACTION WRITTEN
11/30/2022
DOCK
ASSIGNED TO EXAMINER
11/29/2022
MAFR
APPLICATION FILING RECEIPT MAILED
05/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/09/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
04/28/2022
Continuous trademark protection
Get notified about every new filing that threatens TAKATA PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.